1. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma. (2nd February 2021) Authors: Diesinger, Torsten; Lautwein, Alfred; Bergler, Sebastian; Buckert, Dominik; Renz, Christian; Dvorsky, Radovan; Buko, Vyacheslav; Kirko, Siarhei; Schneider, Edith; Kuchenbauer, Florian; Kumar, Mukesh; Günes, Cagatay; Genze, Felicitas; Büchele, Berthold; Simmet, Thomas; Haslbeck, Martin; Masur, Kai... Other Names: Granito Alessandro Academic Editor. Journal: Canadian journal of gastroenterology & hepatology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis. Issue 6 (26th March 2021) Authors: Diesinger, Torsten; Lautwein, Alfred; Buko, Vyacheslav; Belonovskaya, Elena; Lukivskaya, Oksana; Naruta, Elena; Kirko, Siarhei; Andreev, Viktor; Dvorsky, Radovan; Buckert, Dominik; Bergler, Sebastian; Renz, Christian; Müller‐Enoch, Dieter; Wirth, Thomas; Haehner, Thomas Journal: Physiological reports Issue: Volume 9:Issue 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗